Cargando…

Long-Term Outcomes of Japanese Type 2 Diabetic Patients With Biopsy-Proven Diabetic Nephropathy

OBJECTIVE: We evaluated the structural-functional relationships and the prognostic factors for renal events, cardiovascular events, and all-cause mortality in type 2 diabetic patients with biopsy-proven diabetic nephropathy. RESEARCH DESIGN AND METHODS: Japanese type 2 diabetic patients with biopsy-...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimizu, Miho, Furuichi, Kengo, Toyama, Tadashi, Kitajima, Shinji, Hara, Akinori, Kitagawa, Kiyoki, Iwata, Yasunori, Sakai, Norihiko, Takamura, Toshinari, Yoshimura, Mitsuhiro, Yokoyama, Hitoshi, Kaneko, Shuichi, Wada, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816871/
https://www.ncbi.nlm.nih.gov/pubmed/24089538
http://dx.doi.org/10.2337/dc13-0298
_version_ 1782477987685335040
author Shimizu, Miho
Furuichi, Kengo
Toyama, Tadashi
Kitajima, Shinji
Hara, Akinori
Kitagawa, Kiyoki
Iwata, Yasunori
Sakai, Norihiko
Takamura, Toshinari
Yoshimura, Mitsuhiro
Yokoyama, Hitoshi
Kaneko, Shuichi
Wada, Takashi
author_facet Shimizu, Miho
Furuichi, Kengo
Toyama, Tadashi
Kitajima, Shinji
Hara, Akinori
Kitagawa, Kiyoki
Iwata, Yasunori
Sakai, Norihiko
Takamura, Toshinari
Yoshimura, Mitsuhiro
Yokoyama, Hitoshi
Kaneko, Shuichi
Wada, Takashi
author_sort Shimizu, Miho
collection PubMed
description OBJECTIVE: We evaluated the structural-functional relationships and the prognostic factors for renal events, cardiovascular events, and all-cause mortality in type 2 diabetic patients with biopsy-proven diabetic nephropathy. RESEARCH DESIGN AND METHODS: Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy (n = 260) were enrolled. Patients were stratified by albuminuria (proteinuria) and estimated glomerular filtration rate (eGFR) at the time of renal biopsy. The outcomes were the first occurrence of renal events (requirement of dialysis or a 50% decline in eGFR from baseline), cardiovascular events (cardiovascular death, nonfatal myocardial infarction, coronary interventions, or nonfatal stroke), and all-cause mortality. RESULTS: The factors associated with albuminuria (proteinuria) regardless of eGFR were hematuria, diabetic retinopathy, low hemoglobin, and glomerular lesions. The factors associated with low eGFR regardless of albuminuria (proteinuria) were age and diffuse, nodular, tubulointerstitial, and vascular lesions. The glomerular, tubulointerstitial, and vascular lesions in patients with normoalbuminuria (normal proteinuria) and low eGFR were more advanced compared to those in patients with normoalbuminuria (normal proteinuria) and maintained eGFR. In addition, compared to patients with micro-/macroalbuminuria (mild/severe proteinuria) and low eGFR, their tubulointerstitial and vascular lesions were similar or more advanced in contrast to glomerular lesions. The mean follow-up period was 8.1 years. There were 118 renal events, 62 cardiovascular events, and 45 deaths. The pathological determinants were glomerular lesions, interstitial fibrosis and tubular atrophy (IFTA), and arteriosclerosis for renal events, arteriosclerosis for cardiovascular events, and IFTA for all-cause mortality. The major clinical determinant for renal events and all-cause mortality was macroalbuminuria (severe proteinuria). CONCLUSIONS: Our study suggests that the characteristic pathological lesions as well as macroalbuminuria (severe proteinuria) were closely related to the long-term outcomes of biopsy-proven diabetic nephropathy in type 2 diabetes.
format Online
Article
Text
id pubmed-3816871
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-38168712014-11-01 Long-Term Outcomes of Japanese Type 2 Diabetic Patients With Biopsy-Proven Diabetic Nephropathy Shimizu, Miho Furuichi, Kengo Toyama, Tadashi Kitajima, Shinji Hara, Akinori Kitagawa, Kiyoki Iwata, Yasunori Sakai, Norihiko Takamura, Toshinari Yoshimura, Mitsuhiro Yokoyama, Hitoshi Kaneko, Shuichi Wada, Takashi Diabetes Care Original Research OBJECTIVE: We evaluated the structural-functional relationships and the prognostic factors for renal events, cardiovascular events, and all-cause mortality in type 2 diabetic patients with biopsy-proven diabetic nephropathy. RESEARCH DESIGN AND METHODS: Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy (n = 260) were enrolled. Patients were stratified by albuminuria (proteinuria) and estimated glomerular filtration rate (eGFR) at the time of renal biopsy. The outcomes were the first occurrence of renal events (requirement of dialysis or a 50% decline in eGFR from baseline), cardiovascular events (cardiovascular death, nonfatal myocardial infarction, coronary interventions, or nonfatal stroke), and all-cause mortality. RESULTS: The factors associated with albuminuria (proteinuria) regardless of eGFR were hematuria, diabetic retinopathy, low hemoglobin, and glomerular lesions. The factors associated with low eGFR regardless of albuminuria (proteinuria) were age and diffuse, nodular, tubulointerstitial, and vascular lesions. The glomerular, tubulointerstitial, and vascular lesions in patients with normoalbuminuria (normal proteinuria) and low eGFR were more advanced compared to those in patients with normoalbuminuria (normal proteinuria) and maintained eGFR. In addition, compared to patients with micro-/macroalbuminuria (mild/severe proteinuria) and low eGFR, their tubulointerstitial and vascular lesions were similar or more advanced in contrast to glomerular lesions. The mean follow-up period was 8.1 years. There were 118 renal events, 62 cardiovascular events, and 45 deaths. The pathological determinants were glomerular lesions, interstitial fibrosis and tubular atrophy (IFTA), and arteriosclerosis for renal events, arteriosclerosis for cardiovascular events, and IFTA for all-cause mortality. The major clinical determinant for renal events and all-cause mortality was macroalbuminuria (severe proteinuria). CONCLUSIONS: Our study suggests that the characteristic pathological lesions as well as macroalbuminuria (severe proteinuria) were closely related to the long-term outcomes of biopsy-proven diabetic nephropathy in type 2 diabetes. American Diabetes Association 2013-11 2013-10-15 /pmc/articles/PMC3816871/ /pubmed/24089538 http://dx.doi.org/10.2337/dc13-0298 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Original Research
Shimizu, Miho
Furuichi, Kengo
Toyama, Tadashi
Kitajima, Shinji
Hara, Akinori
Kitagawa, Kiyoki
Iwata, Yasunori
Sakai, Norihiko
Takamura, Toshinari
Yoshimura, Mitsuhiro
Yokoyama, Hitoshi
Kaneko, Shuichi
Wada, Takashi
Long-Term Outcomes of Japanese Type 2 Diabetic Patients With Biopsy-Proven Diabetic Nephropathy
title Long-Term Outcomes of Japanese Type 2 Diabetic Patients With Biopsy-Proven Diabetic Nephropathy
title_full Long-Term Outcomes of Japanese Type 2 Diabetic Patients With Biopsy-Proven Diabetic Nephropathy
title_fullStr Long-Term Outcomes of Japanese Type 2 Diabetic Patients With Biopsy-Proven Diabetic Nephropathy
title_full_unstemmed Long-Term Outcomes of Japanese Type 2 Diabetic Patients With Biopsy-Proven Diabetic Nephropathy
title_short Long-Term Outcomes of Japanese Type 2 Diabetic Patients With Biopsy-Proven Diabetic Nephropathy
title_sort long-term outcomes of japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816871/
https://www.ncbi.nlm.nih.gov/pubmed/24089538
http://dx.doi.org/10.2337/dc13-0298
work_keys_str_mv AT shimizumiho longtermoutcomesofjapanesetype2diabeticpatientswithbiopsyprovendiabeticnephropathy
AT furuichikengo longtermoutcomesofjapanesetype2diabeticpatientswithbiopsyprovendiabeticnephropathy
AT toyamatadashi longtermoutcomesofjapanesetype2diabeticpatientswithbiopsyprovendiabeticnephropathy
AT kitajimashinji longtermoutcomesofjapanesetype2diabeticpatientswithbiopsyprovendiabeticnephropathy
AT haraakinori longtermoutcomesofjapanesetype2diabeticpatientswithbiopsyprovendiabeticnephropathy
AT kitagawakiyoki longtermoutcomesofjapanesetype2diabeticpatientswithbiopsyprovendiabeticnephropathy
AT iwatayasunori longtermoutcomesofjapanesetype2diabeticpatientswithbiopsyprovendiabeticnephropathy
AT sakainorihiko longtermoutcomesofjapanesetype2diabeticpatientswithbiopsyprovendiabeticnephropathy
AT takamuratoshinari longtermoutcomesofjapanesetype2diabeticpatientswithbiopsyprovendiabeticnephropathy
AT yoshimuramitsuhiro longtermoutcomesofjapanesetype2diabeticpatientswithbiopsyprovendiabeticnephropathy
AT yokoyamahitoshi longtermoutcomesofjapanesetype2diabeticpatientswithbiopsyprovendiabeticnephropathy
AT kanekoshuichi longtermoutcomesofjapanesetype2diabeticpatientswithbiopsyprovendiabeticnephropathy
AT wadatakashi longtermoutcomesofjapanesetype2diabeticpatientswithbiopsyprovendiabeticnephropathy
AT longtermoutcomesofjapanesetype2diabeticpatientswithbiopsyprovendiabeticnephropathy